Pharmaceutical Cold Chain Logistics: Ensuring 2-8°C Temperature Compliance for Vaccine and Biologic Transport in 2026
By NEWBASE Pharmaceutical Solutions Team | Published April 30, 2026 | 14 min read The global pharmaceutical cold chain logistics market is experiencing unprecedented growth, driven by the expanding distribution of mRNA vaccines, monoclonal antibodies, cell and gene therapies, and other biologics that require precision temperature control throughout the supply chain. According to market analysis from Yahoo Finance (2025), the North America pharmaceutical cold chain segment is projected to grow at a compound annual rate exceeding 12% through 2033, making it one of the fastest-growing segments in the broader cold chain industry. For transport operators, pharmaceutical cold chain represents both an opportunity and a challenge: the cargo is extraordinarily valuable (some shipments […]










